Pro-T ALL: Immunophenotypical analyses

Journal of Biological Regulators and Homeostatic Agents

Volumn 18, Issue 3-4, 2004, Pages 327-330

  Béné, Marie C ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

ALL; Immunophenotype; Pathophysiology; Pro T; T I

Indexed keywords

CD3 ANTIGEN; CD7 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE MARROW; CELL MATURATION; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; MEDLINE; PROLYMPHOCYTE; PUBLICATION; REVIEW; T LYMPHOCYTE; ARTICLE; CELL LINEAGE; IMMUNOLOGY; T CELL LEUKEMIA;

ANIMALIA;

CELL LINEAGE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, T-CELL, ACUTE;

EID: 17844411451     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Béné MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783-6.
2. Garand R, Voisin S, Papin S, et al. Characteristics of pro-T ALL subgroups: Comparison with late T-ALL. Leukemia 1993; 7: 161-7.
3. Nagano M, Kimura N, Akiyoshi T, et al. T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombination. Leuk Res 1997; 21: 763-73.
4. Hashimoto S, Toba K, Aoki S, et al. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: A case report. Leuk Res 2002; 26: 215-9.
5. - acute leukemia: A syndrome of malignant pluripotent lymphohematopoietic cells. Blood 1989; 73: 381-90.
6. Sperling C, Schwartz S, Buchner T, Thiel E, Ludwig WD. Expression of the stem cell factor receptor C-KIT (CD117) in acute leukemias. Haematologica 1997; 82: 617-21.
7. Béné MC, Bernier M, Casasnovas RO, et al. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. Blood 1998; 92: 596-9.
8. Karawajew L, Ruppert V, Wuchter C, et al. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia. Blood 2000; 96: 297-306.
9. Burger R, Hansen-Hagge TE, Drexler HG, Gramatzki M. Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: Suggestion for classification by immunophenotype and T-cell receptor studies. Leuk Res 1999; 23: 19-27.
10. DeCastro CM, Denning SM, Langdon S, et al. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes. Exp Hematol 1994; 22: 1025-33.
11. Lee CK, Kim K, Geiman TM, Murphy WJ, Muegge K, Durum SK. Cloning thymic precursor cells: Demonstration that individual pro-T1 cells have dual T-NK potential and individual pro-T2 cells have dual alphabeta-gammadelta T cell potential. Cell Immunol 1999; 191: 139-44.
12. Carlyle JR, Michie AM, Furlonger C, et al. Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med 1997; 186: 173-82.
13. Lee CK, Kim JK, Kim Y, et al. Generation of macrophages from early T progenitors in vitro. J Immunol 2001; 166: 5964-9.
14. Haks MC, Oosterwegel MA, Blom B, Spits HM, Kruisbeek AM. Cell-fate decisions in early T cell development: Regulation by cytokine receptors and the pre-TCR. Semin Immunol 1999; 11: 23-37.
15. Agosti V, Corbacioglu S, Ehlers I, et al. Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. J Exp Med 2004; 199: 867-78.
16. Sykes DB, Kamps MP. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice. Mol Cell Biol 2004; 24: 1256-69.